Clinicians discuss the rapidly evolving therapies, technology, and surgical approaches for early-stage NSCLC and take a fresh look at the future of care.

NYU lung cancer specialists discuss advances in adjuvant therapy for non–small cell lung cancer, including targeted therapy.

Indiana University staff discuss their outreach to the Black community and how these efforts could lead to more equitable therapeutic outcomes.

Thoracic specialists discuss surgical interventions for early-stage NSCLC and weigh the value of neoadjuvant therapy in operable and locally advanced disease.

Clinicians discuss the evolving therapeutic landscape for Alzheimer's and offer high expectations for recent clinical trials targeting beta amyloid.